Ekso Bionics shares rise amid merger excitement
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 05 Jan 26
Source: 4
Ekso Bionics Holdings Inc (EKSO) saw a price increase of 5.60%, crossing above its 5-day SMA, reflecting positive investor sentiment.
This surge is attributed to the announcement of a proposed merger with Applied Digital Cloud to form ChronoScale, which aims to address the growing demand for AI workloads. The merger is expected to close in the first half of 2026, enhancing competitive positioning and operational flexibility for both companies.
The implications of this merger are significant, as it positions Ekso Bionics to leverage the robust financial performance of Applied Digital Cloud, which generated approximately $75.2 million in revenue over the past year, potentially unlocking further value for shareholders.
Analyst Views on EKSO
About EKSO
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
